The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Philippe De Wals

Department of Social and Preventive Medicine

Laval University

1050 Avenue de la Médecine

Quebec City

Canada

[email]@msp.ulaval.ca

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Department of Social and Preventive Medicine, Laval University, 1050 Avenue de la Médecine, Quebec City, Canada. 2003 - 2011
  • Laval University, Quebec, Canada. 2007
  • Faculty of Medicine, Laval University, and Quebec National Institute of Public Health, Canada. 2006
  • Laval University, and Quebec National Public Health Institute, Department of Social and Preventive Medicine, Pavillon de l'Est, Canada. 2006
  • Department of Community Health Sciences, University of Sherbrooke, 3001 12th Avenue North, Sherbrooke. 2002

References

  1. Optimizing the acceptability, effectiveness and costs of immunization programs: the Quebec experience. De Wals, P. Expert. Rev. Vaccines (2011) [Pubmed]
  2. Analysis of mortality following a mass immunization campaign with serogroup C meningococcal conjugate vaccine: methodological difficulties and imperfect solutions. De Wals, P., Deceuninck, G., Ouakki, M., Boulianne, N., De Serres, G., Danzig, L. Vaccine (2009) [Pubmed]
  3. Modeling the impact of a new vaccine on pneumococcal and nontypable Haemophilus influenzae diseases: a new simulation model. De Wals, P., Black, S., Borrow, R., Pearce, D. Clin. Ther (2009) [Pubmed]
  4. Spina bifida before and after folic acid fortification in Canada. De Wals, P., Tairou, F., Van Allen, M.I., Lowry, R.B., Evans, J.A., Van den Hof, M.C., Crowley, M., Uh, S.H., Zimmer, P., Sibbald, B., Fernandez, B., Lee, N.S., Niyonsenga, T. Birth Defects Res. Part A Clin. Mol. Teratol. (2008) [Pubmed]
  5. Impact of folic acid food fortification on the birth prevalence of lipomyelomeningocele in Canada. De Wals, P., Van Allen, M.I., Lowry, R.B., Evans, J.A., Van den Hof, M.C., Crowley, M., Tairou, F., Uh, S.H., Sibbald, B., Zimmer, P., Fernandez, B., Lee, N.S., Niyonsenga, T. Birth Defects Res. Part A Clin. Mol. Teratol. (2008) [Pubmed]
  6. Reduction in neural-tube defects after folic acid fortification in Canada. De Wals, P., Tairou, F., Van Allen, M.I., Uh, S.H., Lowry, R.B., Sibbald, B., Evans, J.A., Van den Hof, M.C., Zimmer, P., Crowley, M., Fernandez, B., Lee, N.S., Niyonsenga, T. N. Engl. J. Med. (2007) [Pubmed]
  7. Relative efficacy of different immunization schedules for the prevention of serogroup C meningococcal disease: a model-based evaluation. De Wals, P., Trottier, P., Pépin, J. Vaccine (2006) [Pubmed]
  8. Immunization strategies for the control of serogroup C meningococcal disease in developed countries. De Wals, P. Expert. Rev. Vaccines (2006) [Pubmed]
  9. Cost-effectiveness of immunization strategies for the control of serogroup C meningococcal disease. De Wals, P., Nguyen, V.H., Erickson, L.J., Guay, M., Drapeau, J., St-Laurent, J. Vaccine (2004) [Pubmed]
  10. Meningococcal C vaccines: the Canadian experience. De Wals, P. Pediatr. Infect. Dis. J. (2004) [Pubmed]
  11. Benefits and costs of immunization of children with pneumococcal conjugate vaccine in Canada. De Wals, P., Petit, G., Erickson, L.J., Guay, M., Tam, T., Law, B., Framarin, A. Vaccine (2003) [Pubmed]
  12. Economic analysis of the 1992-1993 mass immunization campaign against serogroup C meningococcal disease in Quebec. De Wals, P., Erickson, L. Vaccine (2002) [Pubmed]
 
WikiGenes - Universities